Erbao Chen

1.9k citations
37 papers · 1.3k · 1 hit paper · h-index 16

Impact in

    • Cancer-related molecular mechanisms research
    • MicroRNA in disease regulation
  • Immunology top 5%
    • Immune cells in cancer

Papers in

    • Cancer, Lipids, and Metabolism 8
    • Cancer-related molecular mechanisms research 7
    • RNA modifications and cancer 5
    • RNA Research and Splicing 4
    • Circular RNAs in diseases 4

Erbao Chen

33 papers receiving 1.3k citations

Hit Papers

Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib 2016 · 662 citations
6620+3+6Years since publication200400600

Peers

Erbao Chen
Comparison fields: 5 of 81
  • Cancer Research 429
  • Immunology 456
  • Hepatology 153
  • Oncology 520
  • Pulmonary and Respiratory Medicine 315
Replace Qihan Fu with:
Qihan Fu China
Jiaqiang Ma China
Jing-Jing Zhao China
Yu Lou China
Andrea Malfettone Spain
Qiu-Zhong Pan China
Liu‐Xiao Yang China
Qin Luo China
Seongyeol Park South Korea
Jie-Yi Shi China
Erbao Chen relative to Qihan Fu China Qihan Fu's profile →
Citations per field
00.5×1.5×
Qihan Fu · 1×
Citations per year

Countries citing papers authored by Erbao Chen

Since Specialization
Citations

This map shows the geographic impact of Erbao Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erbao Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erbao Chen more than expected).

Fields of papers citing papers by Erbao Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erbao Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erbao Chen. The network helps show where Erbao Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Erbao Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Erbao Chen Line = papers co-authored together Erbao Chen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib
Hit paper breakdown →
2016662
2 201996
3 201984
4 201566
5 201636
6 201833
7 202229
8 201929
9 201925
10 202225
11 202322
12 202021
13 201821
14 201820
15 201916
16 201715
17 201915
18 202314
19 202013
20 201913

About Erbao Chen

Erbao Chen is a scholar working on Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine, Surgery and Oncology, having authored 37 papers that have together received 1.3k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (9 papers), Cancer, Lipids, and Metabolism (8 papers), Cancer-related molecular mechanisms research (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), RNA modifications and cancer (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), RNA Research and Splicing (4 papers) and Circular RNAs in diseases (4 papers). The work is most often cited by research in Cancer Research (429 citations), Immunology (456 citations), Hepatology (153 citations), Oncology (520 citations) and Pulmonary and Respiratory Medicine (315 citations). Erbao Chen has collaborated with scholars based in China, Saudi Arabia and Ethiopia. Frequent co-authors include Zhi Dai, Zheng‐Jun Zhou, Jian Zhou, Jia Fan, Shao‐Lai Zhou, Zhiqiang Hu, Xiaowu Huang, Zheng Wang, Ya Cao and Tianshu Liu. Their work appears in journals such as Annals of Translational Medicine, Oncotarget, Aging, Cancer Management and Research and BioMed Research International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact